9 results
FDA-Approved 1st line Medications for Tobacco Cessation Treatment

Nicotine patch, Nicotine lozenge, Nicotine gum, Nicotine inhaler, Nicotine
Tobacco Cessation Treatment ... SR) (tablet) #Pharmacology ... Cessation #Therapy #Comparison ... #Table #Agents ... #Dosing
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
Comparison of anti-diabetic ... There are numerous ... #pharmacology #pharmacotherapy ... #table #comparison ... endocrinology #treatment
ANGIOTENSIN II RECEPTOR ANTAGONIST (ARB) DOSING:
TOOL FOR SWITCHING BETWEEN AGENTS IN CANADA
The information provided is intended
) DOSING: TOOL ... SWITCHING BETWEEN AGENTS ... an alternative agent ... ReceptorBlocker #Pharmacology ... #Conversion #Switching
PDE5 inhibitors are usually the drugs of first choice for erectile dysfunction.

PDE5 inhibitors enhance an erection that is
PDE5 inhibitors are ... #pharmacology #comparison ... #treatment #medications ... #dosing #drugs
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
Individualized Treatment ... over injectable agents ... MDRTB #management #Treatment ... antimicrobials #regimens #pharmacology ... #dosing #idsa #
Antiplatelet Conversion - Switching Between Oral P2Y12 Inhibitors
A, Switching between oral agents in the acute/early phase.
Antiplatelet Conversion ... Switching between oral agents ... of patients who are ... the timing and dosing ... ticagrelor #prasugrel #pharmacology
Atrial Fibrillation RVR - Medications
Diltiazem
 • Preferred in patients with chronic lung such as Asthma and
strongly consider using ... the agent for rate ... with digoxin, are ... Medications #management #treatment ... #comparison #table
Acute limb ischemia (ALI)

Rapid decrease in lower limb blood flow due to acute occlusion of peripheral
symptoms of ALI are ... pathophysiology: ... diseased arteries during ... angioplasty balloons, & stents ... #endovascular #treatment
Management of Anthracyclines and HER2 Antagonist Cardiotoxicity
Anthracyclines cause cardiomyopathy:
 ✖ Reduction in left ventricular ejection fraction
HER2 agents cause ... attributed to HER2 agents ... ) and initiate treatment ... every 3 months during ... cardiology #oncology #pharmacology